×

What Cramer expects from IPO market

9:08 AM ET Mon, 12 May 2014

Allergan has rejected a $47 billion takeover bid by Valeant Pharmaceuticals. The "Squawk on the Street" news team discuss m&a in pharmaceuticals and the IPO market.